Literature DB >> 10551934

[Optimal duration of primary surgery with regards to a "Borderline"-situation in polytrauma patients. Arbeitsgemeinschaft "Polytrauma" der Deutschen Gesellschaft für Unfallchirurgie].

H Pape1, M Stalp, M Dahlweid, G Regel, H Tscherne.   

Abstract

Primary stabilization of major fractures in polytrauma patients is known to represent an important principle of treatment and has been shown to reduce the incidence of posttraumatic complications and of organ failure. However, in critically injured patients it has been discussed that extensive primary definitive treatment may also cause adverse effects due to its systemic burden by blood loss, loss of temperature etc. Patients who deteriorated unexpectedly following primary surgery have been named "borderline patients". In these patients it appears necessary to limit the amount of operative procedures, e. g. by performing temporary fixation of major fractures primarily. The threshold beyond which surgical procedures may cause more harm than good has not been well defined. This holds true especially for the duration of primary surgery. We investigated the clinical outcome in a large number of prospectively documented multiple trauma patients with respect of the duration of primary fracture stabilization. If a primary surgical procedure exceeded 6 hours in multiple trauma patients with an ISS of 25 points, patients demonstrated a significantly elevated ventilation time, an increased mortality, and a higher incidence of death from MOF in comparison with patients that were injured comparably, but were submitted to shorter primary operative procedures.

Entities:  

Mesh:

Year:  1999        PMID: 10551934     DOI: 10.1007/s001130050495

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  20 in total

Review 1.  [Operative treatment strategies for multiple trauma patients : early total care versus damage control].

Authors:  T Klüter; S Lippross; S Oestern; M Weuster; A Seekamp
Journal:  Chirurg       Date:  2013-09       Impact factor: 0.955

Review 2.  [Damage control orthopedics].

Authors:  D Nast-Kolb; S Ruchholtz; C Waydhas; B Schmidt; G Taeger
Journal:  Unfallchirurg       Date:  2005-10       Impact factor: 1.000

Review 3.  [Management of spine injuries in polytraumatized patients].

Authors:  C E Heyde; W Ertel; R Kayser
Journal:  Orthopade       Date:  2005-09       Impact factor: 1.087

Review 4.  [The TraumaRegister DGU® dataset, its development over 25 years and advances in the care of severely injured patients].

Authors:  H Trentzsch; M Maegele; U Nienaber; T Paffrath; R Lefering
Journal:  Unfallchirurg       Date:  2018-10       Impact factor: 1.000

5.  [Management of polytrauma].

Authors:  D Nast-Kolb; S Ruchholtz; C Waydhas; G Taeger
Journal:  Chirurg       Date:  2006-09       Impact factor: 0.955

Review 6.  [Management strategies in the first operative phase after long-bone injury of the lower extremity in multiple-injured patients. A systematic literature review].

Authors:  D Rixen; S Sauerland; H-J Oestern; B Bouillon
Journal:  Unfallchirurg       Date:  2005-10       Impact factor: 1.000

Review 7.  [Strategies for surgical treatment of multiple trauma including pelvic fracture. Review of the literature].

Authors:  M Burkhardt; U Culemann; A Seekamp; T Pohlemann
Journal:  Unfallchirurg       Date:  2005-10       Impact factor: 1.000

8.  The treatment of patients with severe and multiple traumatic injuries.

Authors:  Edmund A M Neugebauer; Christian Waydhas; Sven Lendemans; Dieter Rixen; Michaela Eikermann; Tim Pohlemann
Journal:  Dtsch Arztebl Int       Date:  2012-02-10       Impact factor: 5.594

Review 9.  [Developments in polytrauma management. Priority-based strategy].

Authors:  N P Haas; T Lindner; H J Bail
Journal:  Chirurg       Date:  2007-10       Impact factor: 0.955

Review 10.  [Decision making and and priorities for surgical treatment during and after shock trauma room treatment].

Authors:  H C Pape; F Hildebrand; C Krettek
Journal:  Unfallchirurg       Date:  2004-10       Impact factor: 1.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.